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Abstract
Background: Invasion is an important early step in the metastatic cascade and is the primary cause of death of
prostate cancer patients. In order to invade, cells must detach from the primary tumor. Cell-cell and cell-ECM
interactions are important regulators of cohesion - a property previously demonstrated to mediate cell detachment
and invasion. The studies reported here propose a novel role for a5b1 integrin - the principle mediator of
fibronectin matrix assembly (FNMA) - as an invasion suppressor of prostate cancer cells.
Methods: Using a combination of biophysical and cell biological methods, and well-characterized prostate cancer
cell lines of varying invasiveness, we explore the relationship between cohesion, invasiveness, and FNMA.
Results: We show that cohesion is inversely proportional to invasive capacity. We also show that more invasive
cells express lower levels of a5b1 integrin and lack the capacity for FNMA. Cells were generated to over-express
either wild-type a5 integrin or an integrin in which the cytoplasmic domain of a5 was replaced with that of a2.
The a2 construct does not promote FNMA. We show that only wild-type a5 integrin promotes aggregate
compaction, increases cohesion, and reduces invasion of the more aggressive cells, and that these effects can be
blocked by the 70-kDa fibronectin fragment.
Conclusions: We propose that restoring capacity for FNMA in deficient cells can increase tumor intercellular
cohesion to a point that significantly reduces cell detachment and subsequent invasion. In prostate cancer, this
could be of therapeutic benefit by blocking an early key step in the metastatic cascade.
Keywords: Fibronectin matrix assembly, Tissue surface tension, Tumor cohesion, Invasion suppression, α5β1
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Background
Invasion is a critical step in the progression of prostate
cancer from a manageable to an intractable disease. In
order to invade, tumor cells must detach from the
tumor mass. It is widely held that the transition to inva-
sion involves changes in the expression of key cell-cell
and cell-ECM adhesion molecules and that these
changes facilitate escape of tumor cells and their subse-
quent spread to other organs in the body. These
changes can also signal shifts in key mechanical proper-
ties of the tumor. One such property, tumor cohesion,
has been demonstrated to influence tumor cell detach-
ment [1-3], and invasiveness of lung [4], muscle [2], and
brain [5] tumors. E-cadherin is the predominant
cadherin that mediates direct cell-cell cohesion in
epithelial tissues. E-cadherin expression in human pros-
tate cancer specimens is significantly down-regulated or
absent in high-grade lesions [6]. Interestingly, absence of
E-cadherin expression is often associated with an up-
regulation of mesenchymal cadherins, including N-cad-
herin and cadherin-11 [7]. In such cases, net cadherin
expression may not necessarily change. Consequently,
the overall cohesion of the tumor may be unaffected.
Changes in the expression levels of other adhesion sys-
tems may also be required to reduce overall tumor
cohesion.
Integrin-ECM interactions play a key role in cell adhe-
sion. In prostate cancer, a switch in both integrin
expression and in the secretion of an aberrant ECM are
associated with progression to invasion [8]. Several stu-
dies have reported deregulation of both a and b
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the a subunits, a5 integrin is down-regulated in adeno-
carcinoma of the prostate [11]. Alpha - 5 integrin inter-
acts with the b1 subunit to form a5b1i n t e g r i n ,t h e
primary receptor for fibronectin [12]. Apart from a sig-
naling role in mediating cell proliferation, migration,
and differentiation, the interaction between a5b1 integ-
rin and fibronectin promotes the polymerization and
assembly of fibronectin into a matrix [13]. Fibronectin
polymerization is a critical regulator of extracellular
matrix organization and stability [14].
Fibronectin matrix assembly (FNMA) has been shown
to markedly influence tissue cohesion [15,16] and to
specify liquid to solid phase transitions of 3D cellular
[17]. Accordingly, down-regulation of a5i n t e g r i nb y
high-grade prostate cancer cells can, in principle, disrupt
matrix assembly, reduce cohesion, and facilitate the
detachment of tumor cells from the mass. This was
recently reported for a series of glioblastoma (GBM)-
derived cell lines. Despite identical pathologic grade,
aggregates from these lines dispersed at markedly differ-
ent rates and dispersal was inversely proportional to
capacity for FNMA. Moreover, restoring FNMA in
GBM cells markedly reduced their ability to disperse by
increasing aggregate cohesion [3]. Little is known
regarding the role of fibronectin matrix assembly in
mediating prostate cancer cell invasion. An earlier
immunohistochemical study showed that in the normal
prostate gland, fibronectin expression was restricted to
the stromal compartment, whereas a5b1 integrin was
predominantly expressed by epithelial cells. In high-
grade prostate cancer the expression pattern of fibronec-
tin was patchy and significantly reduced, suggesting
either down-regulation of fibronectin secretion or lack
of significant organization into a matrix. The study also
explored fibronectin secretion by LNCaP cells. Interest-
ingly, incubation of LNCaP cells with an anti-fibronectin
antibody resulted in decreased substrate adhesion, sug-
gesting a functional role of a5b1 integrin-fibronectin
interaction [18]. These studies implicate a role for
FNMA in potentially mediating cohesion and invasion
in prostate cancer. Accordingly, we set out to determine
whether prostate cancer cell lines of different invasive
potentials also differed markedly in their capacity for
FNMA and if so, whether this was connected to differ-
ences in cohesion.
The model we chose to use is the Dunning rat pros-
tate cancer model [19]. This model is ideal for these stu-
dies since lines have been established that are
differentially invasive and metastatic [20], and that also
display differential adhesion to various ECM compo-
nents, including fibronectin [21]. None of the lines used
e x p r e s sE - c a d h e r i no nt h e i rs u r f a c e[ 2 2 ] .W ef i r s ts e t
out to measure the cohesivity of aggregates of three cell
lines; the none tumorigenic JHU-3, the tumorigenic but
none-invasive AT-2, and the anaplastic, invasive, and
metastatic cell line MAT-LyLu (MLL). Cohesion was
measured by tissue surface tensiometry (TST). The bio-
physical concepts underlying TST have been previously
described in detail [23,24]. This method entails the com-
pression of spherical aggregates between parallel plates
in a custom-built tensiometer chamber [25]. Compres-
sions are conducted under physiological conditions and
proceed until aggregates reach shape and force equili-
brium, whereupon, aggregateg e o m e t r ya n dt h er e s i s -
tance force are measured. These measurements are then
applied to the Young-Laplace equation [26], generating
measurements of aggregate cohesion, otherwise expres-
sible as tissue surface tension. We next assessed FNMA
by the three lines. To establish a functional role for
FNMA, we generated cell lines that express either wild-
type a5 integrin, or a chimeric construct in which the
cytoplasmic domain of a5 was switched to that of a2
integrin, an integrin that does not support FNMA [16].
We then explored effects on FNMA, aggregate compac-
tion, cohesion, and invasion. We also treated MLL cells
with AZD6244, a selective MEK-inhibitor previously
demonstrated to promote FNMA and explored its’ effect
on aggregate cohesion, tumor cell detachment, and actin
organization.
We showed that multi-cellular aggregates of the three
Dunning lines exhibit different levels of cohesion that
correlate inversely with their invasiveness. We also
demonstrated a correlation between aggregate cohesion
and FNMA. Moreover, we establish a functional role for
FNMA in mediating tumor cell detachment by showing
that restoring matrix assembly of invasive cells renders
them significantly less invasive. This is the first demon-
stration that the fibronectin matrix can act as an inva-
sion suppressor by effectively increasing the cohesion of
3D aggregates of prostate cancer cells.
Methods
Cell lines
Three well-characterized cell lines from the Dunning rat
prostate cancer model [19,27] were used for all studies.
JHU-3 cells were obtained from the American Type
Culture Collection (ATCC, Manassas, VA). MAT-LyLu
and AT-2 cells were a kind gift from Dr. William Isaacs
(Johns Hopkins University). JHU-3 and MAT-LyLu
(MLL) cells were maintained in RPMI-1640 medium
(Invitrogen, Carlsbad, CA) supplemented with 10% fetal
calf serum (FCS, Hyclone, Rockford, IL), 1% non-essen-
tial amino acids (NEAA, Invitrogen), 1% antibiotic/anti-
mycotic (AA, Invitrogen), and 250 nM dexamethasone
(Sigma, St. Louis, MO). AT-2 cells were maintained in
DMEM supplemented with 10% FCS, 1% NEAA, and
1% AA mixture. Normal rat fibroblasts (Rat-2) were
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supplemented with 10% FCS and 1% AA.
Treatment of MLL cells with the MEK inhibitor AZD6244
When required, MLL cells were plated at 60% conflu-
ence, allowed to adhere for 24 hours, then treated over-
night with 1.5 μM of AZD6244, or with a corresponding
volume of DMSO as a carrier control. Cells were then
used as described below for generation of spheroids for
measurement of aggregate cohesion by TST, for assess-
ment of FNMA by immunofluorescence or immunoblot
assay, and to perform 2D and 3D assays.
Measurement of aggregate cohesion by tissue surface
tensiometry
Detailed methods describing the procedure have been
previously published [3,23,24] and are presented in
“Additional file 1.”
Invasion assays
Assays were performed using both single cell suspen-
sions and 3D aggregates. Cells were detached with 0.5
g/L Trypsin-0.2 g/L EDTA (TE, Invitrogen), counted
using a BioRad TC10 automated cell counter, and resus-
pended at a concentration of 5 ×10
5 cells/ml in serum-
free DMEM. 100 μl were plated into either BD Biocoat
Matrigel transfilter invasion chambers or control inserts
lacking a Matrigel barrier (BD Biosciences, Bedford,
MA). Immediately after adding cells, 100 μlo fs e r u m -
free medium was added to each chamber and these
were then transferred into wells of a 24-well tissue cul-
ture plate containing 250 μl of 10x conditioned medium
as a chemo-attractant. Chambers were incubated for 24
hours, whereupon cells on the top surface of the filter
were scraped off using a cotton swab moistened with
serum-free DMEM. Filters were then transferred to
fresh wells containing 300 μlo fa1μM solution of the
fluorescent nuclear dye Syto-16 (Invitrogen, Carlsbad,
CA). Images of fluorescent nuclei of cells that had tra-
versed the membranes from four-10x fields for each
insert were captured using a Nikon Eclipse TE 300 epi-
fluorescence microscope connected to a CoolSnap ES
digital camera. Image analysis was performed using Ima-
geJ. The invasion index was calculated by dividing the
number of invading cells (Matrigel filters) by the num-
ber of migrating cells (control inserts). For 3D invasion
assays, cell suspensions were adjusted to a concentration
of 1 × 10
6 cells/ml and 10 μl hanging drops were
formed as described in Additional file 1. Aggregates ran-
ging in size from 50-70 μm were placed into Matrigel
invasion chambers (Becton-Dickinson, MA) containing
serum-free medium and transferred into wells of a 24-
well plate containing 250 μl of 10x-conditioned medium
as a chemo-attractant. A total of nine aggregates from
each cell line were placed, three aggregates per well, in
nine invasion chambers. After 24 hours in culture, a
cotton swab was used to remove the aggregates and
non-invading cells from the top of the filter. Cells that
had traversed the membrane were stained and quanti-
fied as described above.
3D growth rate assay
In order to determine whether AZD treatment could
influence the growth rate of aggregates of MLL cells,
thereby contributing to any observed differences in the
number of cells counted on the underside of the mem-
brane, hanging drops of MLL-DMSO and MLL-
AZD6244 were generated and incubated for a period
of time corresponding to that used for the invasion
assays. Typically, batches of aggregates were incubated
for 5-days at which time 10 aggregates from each
batch were pooled and dissociated in trypisn-EDTA.
The number of cells were counted for days 6-8. Linear
regression analysis was then used to determine
whether growth rates differed between DMSO and
AZD-6244 treated cells.
Assessment of fibronectin matrix assembly and actin
organization by immunofluorescence (IF) microscopy
For assessment of FNMA, cells were plated into 24-
well tissue culture plates at a density of 5 × 10
5 cell/
ml in tissue culture medium containing 10% fibronec-
tin-depleted FCS. Serum was depleted of fibronectin by
incubation with Gelatin Sepharose 4B (GE Healthcare,
Piscataway, NJ) as previously described [28]. Thirty-μg/
ml of rat plasma fibronectin (Calbiochem, Los Angeles,
CA) was added to each well and the plates were incu-
bated for 24 hours under standard conditions. After 24
hours in culture, cells were washed twice with HBSS
and blocked in CAS-Block buffer (Invitrogen, Carlsbad,
CA) for 30 minutes. Fibronectin matrix was detected
by incubating cells in anti-FN antibody (ab6584,
Abcam, Cambridge, MA) for one hour at RT, and
again after 3 washes with HBSS, in Alexafluor-568 or
Alexafluor 488 secondary antibody (Invitrogen, Carls-
bad, CA) for 30 minutes. After washing twice with
HBSS, cells were counterstained with DAPI and
imaged by epifluorescence microscopy. Images from
the red or green and UV channels were captured and
merged in IPLab imaging software. For assessment of
actin organization, cells were washed in PBS, then
fixed and permeabilized in 4% paraformaldahyde/0.1%
Triton X-100 for 15 minutes at room temperature.
After washing with PBS, cells were incubated in 1:40
rhodamine-phalloidin (Invitrogen, Carlsbad, CA):PBA
and 1:1000 DAPI for 15 minutes, rinsed 2X in PBS,
mounted in Fluorosave reagent (Calbiochem) and
imaged as described above.
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The assembly of high molecular weight FN multimers
(HMWFM) was assessed using deoxycholic acid (DOC)
differential solubilization as previously described [16,29].
Cells were lysed in a DOC lysis buffer (2% w/v sodium
deoxycholate, 20 mM Tris-HCl pH 8.8, 2 mM PMSF, 2
mM EDTA, 2 mM iodoacetic acid, and 0.2 mM N-ethyl-
maleimide), passed through a 26-gauge needle, and cen-
trifuged at 16,000 xg for 15 minutes at 4°C. The
supernatant containing the DOC soluble fraction was
transferred to a fresh tube. The pellet from the 15-min-
ute spin, representing the DOC-insoluble fraction, was
solubilized using SDS lysis buffer (1% SDS, 20 mM Tris-
H C l ,p H8 . 8 ,2m MP M S F ,2m ME D T A ,2m Mi o d o a -
cetic acid, and 0.2 mM N-ethylmaleimide). Protein frac-
tions were separated by SDS-PAGE under reducing
conditions. Protein was transferred to PVDF and
blocked for 4 hours in 5% nonfat dry milk/TBST
(Blotto). Blots were then incubated in anti-FN antibody
(ab6584, Abcam, Cambridge, MA) at a concentration of
1:2,000 in Blotto at 4°C for 16 hours. After several
washes in TBST, blots were probed with streptavidin-
HRP (1:5,000 in Blotto) for 1 hour at room temperature,
washed, and developed using enhanced chemilumines-
cence (Western Blot Detection System, GE Healthcare).
Blots were also probed for Actin (A2066, Sigma, St.
Louis, MO) to control for equal loading.
Assessment of a5b1 cell surface integrin expression by
flow cytometry
Cells were detached from near-confluent tissue culture
plates with TE (Invitrogen, Carlsbad, CA), washed three
times with ice-cold HBSS, and resuspended at a concen-
tration of 1 × 10
7 cells/ml. One hundred μl aliquots, in
duplicate, were deposited into 15-ml conical centrifuge
tubes. Five μg/ml of anti-integrin antibody (a5/FnR
mouse monoclonal P1D6, Calbiochem, Billerica, MA)
was added to one of the duplicates and tubes were incu-
bated on ice for 30 minutes with agitation. After two
washes with HBSS, cells were re-suspended in a 1:100
dilution of Alexa-Fluor 488-conjugated goat-anti-mouse
IgG (Invitrogen, Carlsbad, CA). After 30 minutes, cells
were washed twice and analyzed using a Becton-Dickin-
son FacsCalibur flow cytometer and CellQuest software.
Mean fluorescence intensity (MFI) values were normal-
ized by subtracting the MFI of IgG-FITC controls from
those of the a5b1 integrin-specific signal.
Generation of Chimeric a5 integrin-expressing cells
MLL cells were transfected by electroporation with 30
μgo fa5 cDNA constructs which encode the extracellu-
lar domain of a5 integrin and the cytoplasmic domain
of either a5 (MLL-X5C5) or a2 integrin (MLL-X5C2)
as described in [30]. Transfected cells were grown for
24 hours, and then selected in 800 μg/ml of G418 until
resistant cells reached 40-50% confluence. Cells were
detached with TE, washed three times with ice-cold
HBSS, and incubated with an anti-human a5b1 integrin
antibody (a5/FnR, Calbiochem) at 5 μg/ml on ice for 45
minutes. Cells were washed with cold HBSS and incu-
bated on ice for an additional 45 minutes with an Alexa-
fluor-488-conjugated goat-anti-mouse secondary
antibody (Invitrogen). Cells expressing similar levels of
a5 integrin were bulk-sorted by FACS (EPICS ALTRA,
Beckman Coulter, FL), expanded, and maintained in 400
μg/ml of G418.
Compaction assay
Ten-microliter hanging drops containing 25,000 cells
each were incubated for 24 hours in complete medium
or medium containing 50 μg/ml of the 70 kDa fibronec-
tin fragment. Within this time frame, cells coalescing at
the bottom of the hanging drops formed sheets. Images
were captured, outlines were automatically traced, and
the number of pixels within the outlines were quantified
using IP Lab imaging software. Data points representing
the mean and standard error for aggregate size in pixels
were calculated from 10 hanging drops each of MLL,
MLL-X5C2, and MLL-X5C5.
Statistical analysis
The mean surface tensions, differences in invasion
index, and compaction of the Dunning lines were com-
p a r e db yA N O V Aa n dT u k e y ’s Multiple comparisons
test. Mean surface tension after the first and second
compressions, and difference between initial applied
force and surface tension were compared by Student’s t-
test. The relationship between surface tension and
aggregate volume and the growth rate data were ana-
lyzed by linear regression.
Results
Tissue surface tension measurements of aggregates of
dunning CaP cells
TST measurements of aggregates of the Dunning lines
reveal that JHU-3 and AT-2 are significantly more cohe-
sive with surface tensions (s) of 9.9 ± 0.6 and 13.1 ± 0.5
dynes/cm, respectively, than those of MLL with a s of
3.2 ± 0.3 dynes/cm, as compared by ANOVA (p <
0.0001) and Tukey’s MCT (Table 1 and Figure 1A). The
TST measurements were validated by showing that (i) s
measured after the first compression (s1) is not signifi-
cantly different than that measured after a second,
greater compression (s2), (ii) the ratio of s2/s1
approaches 1, (iii) the ratio of the initial applied force at
both compressions (F2/F1) is significantly greater than
the ratio of s2/s1 (Table 2), and (iv) that s is indepen-
dent of aggregate volume (Figure 1B).
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surface tension
As can be seen in Figure 2, JHU-3 cells are, for all prac-
tical purposes, non-invasive, with an index of 0.023 ±
0.008, whereas AT-2 appear to be somewhat more inva-
sive with an index of 0.47 ± 0.06. MLL cells are the
most invasive, with an index of 0.94 ± 0.18. In general,
invasive index appears to be inversely proportional to
surface tension, with MLL cells being the least cohesive
and most invasive, whereas JHU-3 and AT-2 cells tend
to be more cohesive and less invasive (ANOVA, p =
0.0003).
Fibronectin matrix assembly by dunning CaP cells
FNMA has been previously shown to mediate cell-cell
cohesion in 3D aggregates [30]. Accordingly, these three
cell lines were assessed for their ability to assemble
fibronectin into a matrix. As can be seen in Figure 3A,
MLL cells lack the capacity for FNMA, whereas AT-2
and JHU-3 tend to assemble a richer fibronectin matrix.
FNMA was also assessed using a differential solubiliza-
tion assay and immunoblot analysis. Figure 3B confirms
that the amount of HMWFM detected by immunoblot
analysis was significantly less in MLL than in AT-2 and
JHU-3 cells. One possible explanation for differential
c a p a c i t yf o rF N M Am a yb ea s s o c i a t e dw i t hd i f f e r e n t
levels of a5b1 integrin receptor expression. Accordingly,
we used flow cytometry to specifically compare cell sur-
face receptor expression by the three Dunning lines. Fig-
ure 3C shows that MLL cells express approximately 7-
fold fewer a5b1 integrin molecules on their surface than
JHU cells. We thus asked whether increasing expression
Table 1 Tissue surface tension measurements of Dunning prostate cancer lines
Line s1 (dynes/cm ± s.e.m.) s2(dynes/cm ± s.e.m.) P s1 vs s2 s1,2(dynes/cm ± s.e.m.)
JHU 10.2 ± 0.9 9.8 ± 0.8 0.66 9.9 ± 0.6
AT-2 12.5 ± 0.7 13.7 ± 0.7 0.23 13.1 ± 0.5
MLL 3.1 ± 0.3 3.3 ± 0.4 0.74 3.2 ± 0.3
MLL-X5C2 2.7 ± 0.3 2.9 ± 0.3 0.56 2.8 ± 0.2
MLL-X5C5 13.6 ± 1.9 13.2 ± 1.6 0.90 13.4 ± 1.1
Rat 2 19.7 ± 1.9 22.8 ± 2.2 > 0.05 21.1 ± 1.4
Figure 1 TST measurements of Dunning rat CaP aggregates.
Comparison of aggregate cohesion by TST shows that aggregates
composed of a 4:1 mixture of JHU-3: Rat-2 and AT-2: Rat-2 are
significantly more cohesive than those of MLL: Rat-2 (ANOVA, p <
0.0001, Tukey’s MCT, JHU-3:AT-2 p < 0.001, JHU-3-MLL p < 0.001, AT-
2:MLL p < 0.001). The data set is comprised of n = 20 JHU-3, n = 21
AT-2, and n = 20 MLL aggregates, representing 40, 42, and 40
compressions, respectively (A). Aggregate cohesion is independent
of volume. The relationship between s and aggregate volume was
assessed by linear regression analysis. For liquid-like aggregates, s
must be independent of volume. This was confirmed by showing
that the correlation coefficient, R
2, of regression lines for MLL, AT-2,
and JHU-3 are 0.23, 0.06, and 0.07, respectively, indicating that s is
independent of volume (B).
Table 2 Confirmation of aggregate liquidity
Line s2/s1 F2/F1 F2/F1
σ2/σ1
P
JHU 0.95 ± 0.03 1.43 ± 0.02 1.54 ± 0.07 < 0.05
AT-2 1.11 ± 0.02 1.43 ± 0.02 1.29 ± 0.03 < 0.05
MLL 1.00 ± 0.04 1.45 ± 0.03 1.45 ± 0.07 < 0.05
MLL-X5C2 1.13 ± 0.04 1.52 ± 0.07 1.39 ± 0.11 < 0.05
MLL-X5C5 1.01 ± 0.08 1.45 ± 0.03 1.57 ± 0.07 < 0.05
Rat 2 1.14 ± 0.05 1.60 ± 0.06 1.40 ± 0.15 < 0.05
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capacity for FNMA and higher aggregate cohesion.
Chimeric a5-integrin expression by MLL cells
We transfected MLL cells with cDNA encoding for
expression of the extracellular domain of a5i n t e g r i n
and the cytoplasmic domains of either a5i n t e g r i n
(X5C5) or a2 integrin (X5C2). Previous studies have
shown that whereas X5C5 can promote the assembly of
a rich fibronectin matrix, expression of X5C2 gives rise
to short, punctate clusters [30]. We then used flow cyto-
metry to generate cell lines that were matched in their
levels of a5-integrin expression. We used unstained
MLL cells to establish baseline endogenous fluorescence
(Figure 4A), and an antibody against the extracellular
domain of human a5 integrin to detect the transfected
protein. Figure 4B shows that the antibody does not
recognize rat a5 integrin, whereas it can readily detect
the transfected X5C2 (4 C) and X5C5 (4D) extracellular
domains. The levels of integrin expression by MLL-
Figure 2 Invasion index of Dunning rat CaP cells.M L Lc e l l sa r e
significantly more invasive than either AT-2 or JHU when invasion
indices are compared by ANOVA (p < 0.0003). Tukey’s MCT detected
a significant difference in invasion index between JHU-3 and AT-2
cells (p < 0.05), JHU-3 and MLL cells (p < 0.001), and AT-2 and MLL
cells (p < 0.05).
Figure 3 FNMA by Dunning CaP cells. Immunofluorescence analysis shows that MLL cells cannot assemble a matrix (A), whereas AT-2 (B) and
JHU-3 (C) cells can do so to some extent. Neither of the CaP cells, however, can assemble a matrix to the same extent as Rat-2 fibroblasts (D),
used here as a positive control. DAPI staining was used to demonstrate equal cell density. Scale bar represents 40 micrometers (A). Biochemical
analysis of FNMA by Dunning cells. The assembly of high molecular weight fibronectin multimers (HMWFM) by MLL, AT-2, and JHU-3 cells was
assessed using DOC differential solubilization and immunoblot analysis. Actin in the soluble fraction was used as a loading control. The presence
of HMWFM is higher in AT-2 and JHU-3 cells than in MLL (B). a5b1 surface expression by Dunning CaP cells. Analysis of normalized MFI for
a5b1 integrin expression by the Dunning lines shows that JHU-3 cells express approximately 5-fold more receptors than AT-2 and 7-fold more
than MLL. MFI was normalized by subtracting the MFI of the IgG-FITC control histogram from that of the a5b1-integrin specific histogram and
expressing net MFI of each cell line relative to that of MLL (C).
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by significant overlap of the histograms (Figure 4). To
quantify the data, we ran the experiment 5 times and
generated values for mean fluorescence intensity (MFI).
MFI for MLL-X5C2 and MLL-X5C5 were 217.8 ± 57.2
and 232.8 ± 88.9 units, respectively. A Student’s t-test
was used to compare the means, and showed that a5
expression levels are not statistically different (p =
0.8447), confirming matched levels of expression.
Integrin expression promotes FNMA by MLL cells
We assessed the effect of integrin expression on FNMA.
As can be seen in Figure 5A, when plated onto tissue cul-
ture plastic, MLL cells tend to form loose colonies that do
not appear to assemble a matrix. MLL-X5C2 cells appear
to form tighter colonies that contain areas in which matrix
assembles in short, punctate fibrils. MLL-X5C5 cells tend
to lift off the plate to form spheres that are loosely
attached to the dish and assemble a denser fibronectin
matrix. This was confirmed by biochemical assessment of
FNMA using a differential solubilization assay and immu-
noblot analysis. Figure 5B shows that only MLL-X5C5
cells (lane C5) express large amounts of HMWFM.
MLL cells expressing different Chimeric integrins
demonstrate different compaction behavior
Figure 6A shows that MLL cells, when placed in hang-
ing drop culture, tend to form loose sheets, whereas
cells expressing X5C2 compact to some degree, but
much less so than MLL-X5C5 cells, which tend to form
much more compact aggregates. This compaction can
be blocked by addition of 50 μg/ml of the 70 kDa frag-
ment of fibronectin. We quantified compaction as a
function of the expressed integrin. Figure 6B shows that
MLL cells form cell sheets that are significantly larger
than either MLL-X5C2 or MLL-X5C5 cells (ANOVA, p
< 0.0001, Tukey’sM C T ,p < 0.001). Moreover, aggre-
gates of MLL-X5C5 are significantly more compact than
those of MLL-X5C2 (Tukey’sM C T ,p < 0.01). MLL
cells incubated with 50 μg/ml of the 70 kDa fragment
were, on average, larger than those generated by
untransfected MLL cells (Tukey’s MCT, p < 0.001), sug-
gesting that the 70 kDa fragment of fibronectin inter-
fered with some endogenous residual capacity for
FNMA by MLL cells.
Figure 4 Cell surface expression of chimeric integrins by MLL
cells. Flow cytometry analysis reveals that MLL cells do not react
with anti-human a5 integrin antibody PD16 (B). In contrast, PD16 is
able to detect expression of the a5 extracellular domain of X5C2 (C)
and X5C5 (D), as denoted by a significant increase in mean peak
channel fluorescence relative to the IgG-FITC controls (A).
Figure 5 Expression of chimeric integrins alters cell-cell
interactions and capacity for FNMA. Phase contrast and
immunofluorescence images of MLL, MLL-X5C2, and MLL-X5C5 cells
show that, whereas untransfected MLL cells tend to form loose
colonies with very low capacity for FNMA, MLL-X5C2 cells form
tighter colonies and acquire a limited capacity for matrix assembly.
In contrast, MLL-X5C5 cells tend to aggregate into spheroids that lift
off the surface of the culture dish. These cells also appear to
assemble a rich fibronectin matrix. DAPI staining was used to
demonstrate equal cell density (A). Biochemical analysis of FNMA by
chimeric integrin-expressing cells. The assembly of high molecular
weight fibronectin multimers (HMWFM) by MLL, MLL-X5C2, and
MLL-X5C5 cells was assessed using DOC differential solubilization
assay. DOC-soluble and insoluble fractions were separated by SDS-
PAGE and analyzed by immunoblotting using an anti-fibronectin
antibody. Actin in the soluble fraction was used as a loading
control. The presence of HMWFM is highest in MLL-X5C5 cells (B).
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Page 7 of 12Integrin expression specifies aggregate cohesion
TST measurements reveal that aggregates of MLL-X5C5
are significantly more cohesive than those that express
t h eX 5 C 2c h i m e r i ci n t e g r i n .T a b l e1a n dF i g u r e7 A
show that aggregates of MLL-X5C5 have a mean surface
tension (s)o f1 3 . 2±1 . 6d y n e s / c m ,s i g n i f i c a n t l yh i g h e r
than those of MLL and MLL-X5C2 that have a s of 3.3
± 0.4 and 2.9 ± 0.3 dynes/cm, respectively, as compared
by ANOVA and Tukey’s MCT. The TST measurements
were validated as described above (Table 2).
Integrin expression by MLL cells inhibits invasion
We assessed whether integrin expression could influence
the ability of MLL cells to escape a 3D spheroid and
invade through an ECM. We performed Matrigel transfil-
ter invasion assays by depositing aggregates of MLL, MLL-
X5C2 or MLL-X5C5 in the upper chamber and counted
the number of cells that invaded into the lower surface of
the filter. Figure 7B shows that aggregates of MLL and
MLL-X5C2 were similar l yi n v a s i v e( T u k e y ’sM C T ,p >
0.05), and significantly more so than aggregates composed
of MLL-X5C5 cells (Tukey’sM C T ,p < 0.001).
The MEK inhibitor AZD6244 promotes FNMA, increases
aggregate cohesion, and decreases tumor cell detachment
Various agents have been previously demonstrated to
promote FNMA by cells deficient in this capacity,
including the MEK inhibitor PD98059. Here, we treated
MLL cells with AZD6244, a MEK inhibitor currently
Figure 6 Compaction of chimeric integrin-expressing cells.
Hanging drop cultures of parent MLL and chimeric integrin-
expressing cells show that expression of the different chimeric
integrins can markedly influence aggregate compaction. When
placed in hanging drop culture, parent MLL cells tend to generate
large cellular sheets. Expression of X5C2 gives rise to more compact
sheets, whereas expression of X5C5 results in even more compact
aggregates. Compaction of MLL-X5C5 cells can be blocked by
incubation in 50 μg/ml 70 kDa fibronectin fragment (A).
Quantification of aggregate compaction. Compaction was quantified
and statistically analyzed by ANOVA and Tukey’s MCT. ANOVA
detected significant size difference within the data set (p < 0.0001).
Tukey’s MCT confirmed that MLL-X5C5 are more compact than MLL
(p < 0.001) and MLL-X5C2 (p < 0.01). Moreover, incubation of MLL-
X5C5 with 50 μg/ml 70 kDa fragment of fibronectin resulted in
aggregates that were on average larger than MLL-X5C5 (p < 0.001)
and MLL (p < 0.001) (B).
Figure 7 TST measurements of chimeric integrin-expressing
aggregates of MLL cells. Comparison of aggregate cohesion by
ANOVA and Tukey’s MCT shows that aggregates of MLL-X5C5 cells
are significantly more cohesive than those of the MLL parent line (p
< 0.001) and MLL-X5C2 (p < 0.001). No difference in cohesion was
detected between MLL and MLL-X5C2 (p > 0.05) (A). In vitro
invasion of chimeric integrin-expressing MLL cells. The number of
cells able to detach from n = 10 aggregates composed of MLL,
MLL-X5C2, and MLL-X5C5, and to invade through a Matrigel filter
was compared. Whereas no difference in invasiveness could be
observed between MLL and MLL-X5C2 (p > 0.05), MLL-X5C5 cells
were significantly less invasive than aggregates of either parent MLL
(p < 0.001) or MLL-X5C2 (p < 0.001) (B). Representative images of
invading cells are included as insets.
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ment with AZD6244 clearly resulted in an increased
capacity for FNMA when assessed by immunofluores-
cence (Figure 8A). This was confirmed by immunoblot
analysis, which revealed that treatment with AZD6244
resulted in a marked increase in high molecular weight
fibronectin multimers (Figure 8B). Restoring capacity for
FNMA also gave rise in a marked increase in aggregate
cohesion as measured by TST. The cohesion of aggre-
gates composed of AZD6244-treated cells was found to
be 17.3 ± 1.4 dynes/cm, whereas the cohesion of aggre-
gates composed of untreated cells was significantly
lower, at 7.3 ± 0.8 dynes/cm (Student’s t-test, p <
0.0001, 8 C). When treated and control cells were spar-
sely plated (2D) into Boyden chambers containing
uncoated filters, the number of cells migrating through
the 8 μm pores were not significantly different from
those treated with the DMSO carrier (Student t-test, p
= 0.4604). However, when 3D aggregates were placed
onto uncoated filters, the number of cells that were able
to detach from the aggregate and migrate through the 8
μm pores was significantly lower for AZD6244-treated
aggregates than for those treated with DMSO (Students
t-test, p = 0.0008) (Figure 8D). To determine whether
AZD6244 could potentially alter growth rate, as this
could influence cell counts, we generated treated and
control aggregates and measured growth rate of the 3D
spheroids. Regression analysis revealed that the devia-
tion from zero slope was not significant for either
DMSO-treated (p = 0.9575) or AZD6244-treated cells (p
= 0.9108). The r
2 values for the regression lines for
DMSO and AZD6244-treated cells were 0.0002273 and
0.001319, respectively, indicating very little to no-growth
within the time-frame of when aggregates were used for
invasion or migration assays. No difference in the slopes
was detected (p = 0.9365) (Additional file 1).
AZD6244 activates a5b1 integrin
Apart from effects of AZD6244 on aggregate cohesion
and cell detachment, we also asked whether treatment
could also influence integrin activation. Figure 9A
demonstrates that AZD6244 has a marked effect on
actin organization and subsequently, on cell shape.
Whereas untreated and DMSO-treated cells tend to
remain somewhat spherical and were loosely adherent
to the tissue culture plate, AZD6244 treatment resulted
in marked cell spreading and flatter cells. This change
Figure 8 AZD6244 promotes FNMA and decreases tumor cell
detachment. MLL cells treated with DMSO as carrier control fail to
assemble a fibronectin matrix, whereas MLL cells treated overnight
with 1.5 μM AZD6244 assemble a matrix as revealed by
immunofluorescnce assay (A). Matrix assembly was confirmed by
differential solubilization assay and immunoblot analysis. The
assembly of high molecular weight fibronectin multimers (HMWFM)
is only evident in AZD62244-treated MLL cells. Actin in the soluble
fraction was used as a loading control (B). AZD6244 treatment also
resulted in increased aggregate cohesion as measured by TST.
Treated aggregates were found to be significantly more cohesive
than aggregates treated with the DMSO carrier (Student t-test, p <
0.0001) (C). The migration of DMSO and AZD6244-treated MLL cells
was not significantly different when cells were sparsely plated into
Boyden chambers containing control filters (Student t-test, p =
0.4604). However, when migration assays were conducted using 3D
spheroids of DMSO and AZD6244-treated cells, detachment of cells
from the aggregate was shown to be significantly delayed by
treatment with the MEK inhibitor (Student t-test, p < 0.0008) (D).
Figure 9 AZD6244 treatment effects actin organization and
reduces invasion. Drug treatment results in a marked re-
organization of the actin cytoskeleton. Here, MLL cells were sparsely
plated and actin staining was performed using rhodamine-
phalloidin and DAPI as a counterstain for nuclei. Actin organization
changed from predominantly cortical for untreated and DMSO-
treated cells to arrangement into stress fibers in response to the
AZD6244 (A). This was accompanied by a change in cell shape from
predominantly spherical and loosely adherent to flatter cells that
appeared to adhere more strongly to the substrate. Immunoblot
analysis revealed no change in either a5b1 integrin expression or in
fibronectin secretion (B).
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the actin cytoskeleton from predominantly cortical into
stress fibers. Interestingly, this does not seem to be asso-
ciated with an overt increase in expression of a5b1
integrin or in the secretion of fibronectin, both of which
could also influence cell attachment (B), suggesting
rather, that integrin function was somehow enhanced.
Discussion
Various cancer cell lines have been previously demon-
strated to generate spheroids when placed in hanging
drop culture, including the lung cancer cell line Lewis
Lung Carcinoma [1], human fibrosarcoma HT-1080
[31], cells of the glioblastoma U87-MG series [3,32], and
breast cancer MCF-7 cells [33]. For these lines, aggre-
gates either spontaneously formed spheroids or were
induced to do so by embedding cells in extracellular
matrix. Two of the three prostate cancer cell lines used
in this study, AT-2 and JHU-3, spontaneously formed
spheroids when placed in hanging drop culture. How-
ever, in order to generate sufficiently large spheroids for
measurement of aggregate cohesion, it was necessary to
admix normal rat fibroblasts with the MLL cells at a
ratio of 1:4. The inclusion of fibroblasts provided suffi-
cient motility within the aggregate to elicit the shape
change required for aggregates to become spherical.
Accordingly, we also admixed fibroblasts with AT-2 or
JHU-3 cells so as to be able to compare aggregate cohe-
sion between lines. We demonstrated an inverse rela-
tionship between aggregate cohesion and invasive index.
We also showed that aggregate cohesion is independent
of size and of the applied force [23,24], confirming that
the TST measurements reflect real differences in cohe-
sion between the three cell lines.
We also established a correlation between aggregate
cohesion and capacity for FNMA. Earlier studies have
ascribed a role for FNMA as a mediator of strong tissue
cohesion in various cell lines including Chinese Hamster
Ovary (CHO) cells [15,16], and cells derived from glioblas-
toma tumors [3]. This is the first demonstration that pros-
tate cancer cells can vary in their ability to assemble a
fibronectin matrix and that this correlates with aggregate
cohesion, a property previously demonstrated to signifi-
cantly influence cell detachment [3], aggregate spreading
onto a substrate [34], and invasive capacity [1,2,32].
Alpha2Beta1 integrin, the receptor for collagen and
other matrix molecules, is significantly down-regulated in
poorly differentiated breast cancer [35], and has been
demonstrated to suppress metastasis in mouse and human
models of breast and prostate cancer [36]. We found a
similar pattern of expression for a5b1; aggressive MLL
cells expressing approximately 7-fold fewer receptors on
their surface than JHU-3 cells. This could explain why
MLL cells are deficient in their capacity to assemble a
fibronectin matrix. Accordingly, we transfected MLL cells
with a5 cDNA and bulk-selected a population of cells of
increased a5b1 expression (MLL-X5C5). This resulted in
increased FNMA, increased aggregate compaction, higher
cohesion, and reduced invasive capacity. Compaction and
cohesion could be blocked by incubation of MLL-X5C5
cells with the 70 kDa fragment of fibronectin, a fragment
previously demonstrated to interfere with FNMA [37].
Accordingly, it was not possible to perform 3D invasion
assays in the presence of the fragment in order to deter-
mine whether blocking matrix assembly results in rescue
of the invasive phenotype. However, transfection of MLL
cells with a chimeric integrin construct in which the cyto-
plasmic domain of a5 integrin was switched to that of a2
integrin (MLL-X5C2) did not increase aggregate cohesion
or decrease invasion. This chimeric construct does not
promote FNMA, rather, the fibronectin becomes localized
in punctata and fibers do not extend between cells [30].
This further confirms that an intact matrix, assembled
into fibers that extend between cells, is necessary to gener-
ate the force required to increase aggregate cohesion and
discourage detachment of tumor cells and their subse-
quent invasion.
We propose that loss of the fibronectin matrix can pro-
mote invasion by facilitating the detachment of cancer
cells from the tumor mass. Accordingly, loss of a5b1
expression or function represents a possible early mechan-
ism whereby cells can proceed further down the metastatic
pathway. Once cells have detached, they become free to
move and undergo intravasation. Interestingly, loss of
a2b1 integrin is associated with increased intravasation of
breast cancer cells [36]. Since a2b1 is a receptor for col-
lagen and other matrix molecules, it is also possible that
loss of this receptor can also give rise to a decrease in
tumor cohesion through decreased integrin-collagen (or
other ECM) interactions in a similar fashion as the cohe-
sion mediated through the interaction of a5b1i n t e g r i n
and fibronectin [15]. Therefore, the combined loss of
a5b1a n da2b1 could, in principle, markedly promote
metastasis by controlling two key steps in the metastatic
cascade: cell detachment and intravasation. The studies
described above focus on integrin heterodimers that tend
to be down-regulated in more aggressive cancers. Other
integrin heterodimers have been shown to be over-
expressed in aggressive tumors. AlphavBeta3 [38] and
avb5 [39], for example, are currently being explored in
clinical trials as potential targets of integrin antagonists
[40]. Our study suggests that it may also be possible to
reduce invasion and metastasis by developing integrin ago-
nists that could act to reactivate integrin expression or
function. This has already been demonstrated for glioblas-
toma cells, where reactivating FNMA by dexamethasone,
the MEK-inhibitor PD98059, or the benzoquinone ansa-
mycin antibiotic Geldanamycin, led to a significant
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persal velocity [3]. More potent and FDA-approved MEK
inhibitors, such as AZD6244, are currently being used in
clinical trials for melanoma. Here we show that treatment
of MLL cells with AZD6244 resulted in restoration of
FNMA by MLL cells and that this manifested in a marked
increase in tumor aggregate cohesion. Interestingly, drug
treatment did not result in differences in the ability of sin-
gle cells to migrate through an 8 μmf i l t e r ,b u tr a t h e r ,
reduced the ability of tumor cells to detach from the 3D
mass.
In conventional 2D cell culture, AZD6244 treatment of
MLL cells resulted in a marked reorganization of the
actin cytoskeleton and enhanced adhesion to the sub-
strate, processes indicative of integrin activation. A recent
report in melanoma cells also showed that AZD6244
induced actin reorganizatio na n dp r o m o t e di n t e g r i n -
mediated adhesion to substrate [41]. Integrin activation
and cytoskeletal interaction are essential for the assembly
of a fibronectin matrix [42]. Extended to 3D culture,
increased affinity of integrin receptors for substrate could
also contribute to the overall increase in aggregate cohe-
sion observed here. On the one hand AZD6244 appears
to promote aggregate cohesion, while on the other hand,
it also appears to increase affinity of integrins for sub-
strate and could, in principle also promote migration of
cells away from the aggregate. These two opposing forces
are physically interdependent. A previous study estab-
lished an interplay between cell-cell and cell-substratum
adhesion in mediating aggregate spreading [34] and it is
likely that a similar relationship exists for aggregates of
MLL cells. A shift in the balance favoring FNMA-
mediated cell-cell cohesion is likely the case here.
Conclusions
Collectively, the data suggest that an increase in tumor
cohesion, mediated by restoration of FNMA, can act to
suppress tumor cell detachment, and that it may be pos-
sible to pharmacologically impact an early step in the
metastatic cascade of prostate cancer.
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